Absalon Michael J, Khoury Ruby A, Phillips Christine L
Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 7018, Cincinnati, Ohio 45229.
Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 7018, Cincinnati, Ohio 45229.
Semin Pediatr Surg. 2017 Aug;26(4):257-266. doi: 10.1053/j.sempedsurg.2017.07.002. Epub 2017 Jul 25.
The post-transplant lymphoproliferative disorders (PTLD) are a diverse group of potentially life-threatening conditions affecting organ transplant recipients. PTLD arises in the setting of an attenuated host immunologic system that is manipulated to allow a foreign graft but then fails to provide adequate immune surveillance of transformed malignant or premalignant lymphocytes. The diversity of biological behavior and clinical presentation makes for a challenging clinical situation for those involved in the care of children with PTLD occurring after solid-organ transplantation. This review details a large transplant center's multidisciplinary approach to monitoring for PTLD and systematic approach to intervention, which has been essential for early recognition and successful treatment.
移植后淋巴细胞增生性疾病(PTLD)是一组影响器官移植受者的、具有潜在生命威胁的多种疾病。PTLD发生于宿主免疫系统减弱的情况下,该系统被操控以允许异体移植物植入,但随后无法对转化的恶性或癌前淋巴细胞提供充分的免疫监测。生物学行为和临床表现的多样性给参与实体器官移植后发生PTLD儿童护理的人员带来了具有挑战性的临床情况。本综述详细介绍了一个大型移植中心对PTLD进行监测的多学科方法以及系统的干预方法,这对于早期识别和成功治疗至关重要。